课题基金 / 基金详情

Structural basis of the specific protein-protein interactions underlying IF assem

Structural basis of the specific protein-protein interactions underlying IF assem
IF 组装背后的特定蛋白质-蛋白质相互作用的结构基础
批准号:
8142487
负责人:
PETER BURKHARD
金额:
$25.46万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-15 至 2016-05-31

项目摘要

项目成果

PETER BURKHARD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
As indicated in the overview section of this PPG, vimentin consists of a central rod domain flanked by nona-helical head and tail domains. The central rod domain reveals a pronounced seven-residue periodicity, (abcdefg)n, in the distribution of apolar residues. Within this repeat, positions a and d are preferentially occupied by small apolar residues like Leu, lie. Met or Val, typical for a so-called coiled-coil structure (1). A coiled coil is formed by two or more a-helices wound around each other in a 'superhelix', and is a widespread structural motif in proteins (2, 3). This common structural motif enables IF proteins to self-assemble into 10-nm filaments in vitro In the absence of any auxiliary proteins or factors. These filaments are rope-like assemblies made from two to six 4.5-nm protofibrils (i.e., containing eight IF polypeptides each) which, in turn, are made of two intertwined 3-nm protofilaments each (4, 5). Although the molecular architecture of the 3-nm protofilament has not yet been precisely defined, it appears to be made from two antiparallel IF dimers, the latter being 2-stranded a-helical coiled-coils (i.e., formed via the central rod domain) of two parallel, in-register IF polypeptides (also see Figure 6).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Peptide Nanoparticle Nicotine Vaccine
  • 批准号:
    8540406
  • 项目类别:
  • 资助金额:
    $75.84万
  • 财政年份:
    2011
  • 负责人:
    PETER BURKHARD
  • 依托单位:
A Peptide Nanoparticle Nicotine Vaccine
  • 批准号:
    8289967
  • 项目类别:
  • 资助金额:
    $78.5万
  • 财政年份:
    2011
  • 负责人:
    PETER BURKHARD
  • 依托单位:
A Peptide Nanoparticle Nicotine Vaccine
  • 批准号:
    8334593
  • 项目类别:
  • 资助金额:
    $78.58万
  • 财政年份:
    2011
  • 负责人:
    PETER BURKHARD
  • 依托单位:
A Peptide Nanoparticle Nicotine Vaccine
  • 批准号:
    8913926
  • 项目类别:
  • 资助金额:
    $77.82万
  • 财政年份:
    2011
  • 负责人:
    PETER BURKHARD
  • 依托单位:
国内基金
海外基金
MUC16 C-terminal/AKT/HK2信号轴在Lewis抗原阴性胰腺癌侵袭转移中的作用及机制研究
  • 批准号:
    82072693
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2020
  • 负责人:
    刘辰
  • 依托单位:
靶向转导Gαi2 C-terminal peptide基因去迷走神经治疗心房颤动的实验研究
  • 批准号:
    81260037
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2012
  • 负责人:
    汤宝鹏
  • 依托单位: